SCHEMBL7625928

SCHEMBL7625928

CCC(CO)CCCCCCCCCCCCCCCCCCCCCCCCCCCC(N)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
LMNA P02545 1/20 0.48
CYP3A4 P08684 2/20 0.41
SOAT1 P35610 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
FAAH O00519 1/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
TSHR P16473 1/20 0.41
ATM Q13315 1/20 0.41
CA2 P00918 3/20 0.40
KDM4E B2RXH2 2/20 0.38
GSTK1 Q9Y2Q3 1/20 0.37
FFAR4 Q5NUL3 1/20 0.36
FFAR1 O14842 1/20 0.36
CA1 P00915 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7623785 1.00 ALDH1A1 (0.54) ALDH1A1LMNACYP3A4SOAT1MEN1
SCHEMBL7624351 1.00 ALDH1A1 (0.54) ALDH1A1LMNACYP3A4SOAT1MEN1
SCHEMBL7620597 0.90 FAAH (0.59) ALDH1A1LMNACYP3A4SOAT1MEN1
SCHEMBL7623434 0.90 FAAH (0.59) ALDH1A1LMNACYP3A4SOAT1MEN1
SCHEMBL7620605 0.90 FAAH (0.59) ALDH1A1LMNACYP3A4SOAT1MEN1
SCHEMBL7619344 0.90 FAAH (0.59) ALDH1A1LMNACYP3A4SOAT1MEN1
SCHEMBL7626538 0.90 ALDH1A1 (0.44) ALDH1A1LMNACYP3A4SOAT1MEN1
SCHEMBL7629370 0.90 FAAH (0.59) ALDH1A1LMNACYP3A4SOAT1MEN1
SCHEMBL7621344 0.90 FAAH (0.59) ALDH1A1LMNACYP3A4SOAT1MEN1
SCHEMBL7624105 0.90 FAAH (0.59) ALDH1A1LMNACYP3A4SOAT1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6444832-B1 OSTEOPOROSIS ESSWEIN ANGELIKA (DE) 2002-09-03 US disclosed
EP-0865422-B1 USE OF AMINOALCOHOLDERIVATIVES AS DRUGS, DERIVATIVES AND PROCESS FOR THEIR PREPARATION ROCHE DIAGNOSTICS GMBH (DE) 2001-07-11 EP disclosed